Fig 3. Effects of miR-106b transfection on the invasive and metastatic ability of ovarian carcinoma cell lines.

After transfection with the miR-106b mimic, ovarian carcinoma cell lines showed (A) lower migration in wound healing assays, and (B) slower invasion in matrigel transwell assays compared with mock-treated cells. Results are representative of three separate experiments; data are expressed as the mean ± standard deviation, * P < 0.05.